Ajax-Loading

Eli Lilly and Company - Cash Ratio

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Cash-Ratio" stands at 0.247 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Cash Ratio" stands at 0.247. This represents an increase of 171.76 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 73.20 percent compared to the value the year prior.
The 1 year change in percent is 73.20.
The 3 year change in percent is 40.98.

The Serie's long term average value is 0.149. It's latest available value, on 09/30/2025, is 65.23 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +171.76%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Cash Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Cash Ratio486,508,953,600.00
LogoAbbVie Inc - Cash Ratio399,570,305,024.00
LogoRoche Holding AG - Cash Ratio317,433,206,677.55
LogoAstraZeneca PLC - Cash Ratio280,205,508,085.11
LogoNovartis AG - Cash Ratio255,096,620,580.91